‘Folfirinox’ chemotherapy combined with contact x-ray brachytherapy 50kVp and ‘CAP50’ chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3... von Mitrea, D., Barbet, N., Pacé-Loscos, T., Scouarnec, C., Ben-Dhia, S., Baron, D., Mineur, L., Évesque, L., Durand-Labrunie, J., Gérard, J.-P., Baudin, G., Doyen, J.

Volltext

‘Folfirinox’ chemotherapy combined with contact x-ray brachytherapy 50 kVp and ‘CAP50’ chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3... von Mitrea, D., Barbet, N., Pacé-Loscos, T., Scouarnec, C., Ben-Dhia, S., Baron, D., Mineur, L., Évesque, L., Durand-Labrunie, J., Gérard, J.-P., Baudin, G., Doyen, J.

Volltext

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: p... von Bang, Y.-J, Ruiz, E.Yañez, Van Cutsem, E., Lee, K.-W, Wyrwicz, L., Schenker, M., Alsina, M., Ryu, M.-H, Chung, H.-C, Evesque, L., Al-Batran, S.-E, Park, S.H., Lichinitser, M., Boku, N., Moehler, M.H., Hong, J., Xiong, H., Hallwachs, R., Conti, I., Taieb, J.

Volltext

Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms? von Evesque, L., Francois, E., Milano, G.

Volltext

L’Orient des écrivains et des savants à l’épreuve de la Grande Guerre: Autour d’Une enquête aux pays du Levant de Maurice Barrès

Volltext

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 tria... von Conroy, T., Castan, F., Etienne, P.-L., Rio, E., Mesgouez-Nebout, N., Evesque, L., Vendrely, V., Artignan, X., Bouché, O., Gargot, D., Boige, V., Bonichon-Lamichhane, N., Louvet, C., Morand, C., de la Fouchardière, C., Boilève, A., Delaye, M., Gourgou, S., Pezzella, V., Borg, C.

Volltext

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma von Fraunhoffer, N., Hammel, P., Conroy, T., Nicolle, R., Bachet, J.-B., Harlé, A., Rebours, V., Turpin, A., Ben Abdelghani, M., Mitry, E., Biagi, J., Chanez, B., Bigonnet, M., Lopez, A., Evesque, L., Lecomte, T., Assenat, E., Bouché, O., Renouf, D.J., Lambert, A., Monard, L., Mauduit, M., Cros, J., Iovanna, J., Dusetti, N.

Volltext

A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma... von Baron, D., Pace Loscos, T., Schiappa, R., Barbet, N., Dost, E., Ben Dhia, S., Soltani, S., Mineur, L., Martel, I., Horn, S., Picardi, C., Stewart, A., Cotte, E., Coquard, R., Baudin, G., Evesque, L., Dhadda, A., Sun Myint, A., Gérard, J.P., Doyen, J.

Volltext

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study von Saint, Angélique, Viotti, J., Borchiellini, D., Hoch, B., Raimondi, V., Hebert, C., Largillier, R., Evesque, L., Follana, P., Ferrero, J. M., Delaby, C., Schiappa, R., Chamorey, E., Barriere, J.

Volltext

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) von Rao, S., Anandappa, G., Capdevila, J., Dahan, L., Evesque, L., Kim, S., Saunders, M.P., Gilbert, D.C., Jensen, L.H., Samalin, E., Spindler, K.-L., Tamberi, S., Demols, A., Guren, M.G., Arnold, D., Fakih, M., Kayyal, T., Cornfeld, M., Tian, C., Catlett, M., Smith, M., Spano, J.-P.

Volltext

Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REG... von Samalin, E., Turpin, A., Khemissa, F., Zaanan, A., Benabdelghani, M., Senellart, H., Gilabert, M., Evesque, L., Dahan, L., Sefrioui, D., Bouché, O., De la Fouchardière, C., Hennequin, A., Monard, L., Gourgou, S., Lopez, A.

Volltext

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse von Kinj, R., Doyen, J., Hannoun-Lévi, J.M., Naghavi, A.O., Chand, M.E., Baudin, G., Ferrero, J.M., François, E., Evesque, L., Borchiellini, D., Benezery, K., Bondiau, P.Y.

Volltext

EP-1267: Induction chemotherapy followed by chemoradiotherapy in locally advanced pancreatic adenocarcinoma von Reure, J, Doyen, J, Falk, A, Lam Cham Kee, D, Evesque, L, Follana, P, François, E, Benezery, K

Volltext

Memoire a ceux qui vont aux Estats, par M. Pierre du Four l'Evesque von Du Four L Évesque, Pierre. Auteur du texte

Volltext bestellen

Nécrose digitale sous pembrolizumab : un évènement thrombotique rare von Levraut, M., Martis, N., Drappier, C., Rocher, F., Rosenthal, E., Fuzibet, J.G., Evesque, L., Queyrel, V.

Volltext

397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in HER2-negative advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma (GC/GEJC): PD-... von Moehler, M., Oh, D-Y., Kato, K., Tabernero, J., Cruz-Correa, M., Wyrwicz, L.S., Cid, R.A. Pazo, Cubillo, A., Evesque, L., Fornaro, L., Dotan, E., Morgan, C., Li, L., Xu, Y., Sheng, T., Yang, S., Hu, H., Xu, R-H.

Volltext

517P Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: The RASINTRO prospective multicenter study von Zaanan, A., Bergen, E.S., Evesque, L., Meurisse, A., Artru, P., Lecomte, T., Bouche, O., Coriat, R., Lievre, A., Cohen, R., Boige, V., Louafi, S., Bachet, J-B., Taieb, J., Vernerey, D., Blons, H., Laurent-Puig, P.

Volltext

102P Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study von He, A.R., Bouattour, M., Gupta, V.G., Evesque, L., Zhen, D.B., Park, J.O., Sookprasert, A., Salvatierra, A., Vaccaro, G.M., Oh, S.C., Ostoich, S.A., Satoh, T., Żotkiewicz, M., Rokutanda, N., Kim, H., Oh, D-Y.

Volltext

SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer von Piquemal, D., Noguier, F., Bournet, B., Ghiringhelli, F., Pierrat, F., Canivet, C., Bertaut, A., Bruno, R., Evesque, L., Gamez, A., Cros, J., Lepage, C., François, E., Louvet, C., Vincent, J., Hennequin, A., Bengrine, L., Afchain, P., Trouilloud, I., Bachet, J.

Volltext

562P Acquired genomic alterations on first-line chemotherapy (CT) + cetuximab in advanced colorectal cancer (mCRC): Circulating tumor (ct)DNA analysis of the randomized phase II tr... von Boige, V., Bouche, O., Mulot, C., Evesque, L., Ben Abdelghani, M., Phelip, J.M., Mineur, L., Galais, M.P., Villing, A-L., Hautefeuille, V., Fouchardiere, C. de la, Genet, D., Lassoued, S., Carnot, A., Mitry, E., Jacquot, S., Serazin, D., Brument, E., Winter, A., Blons, H.

Volltext